Hana Pharm Co., Ltd. (KRX:293480)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,790
0.00 (0.00%)
At close: Sep 5, 2025
Market Cap209.19B
Revenue (ttm)139.33B
Net Income (ttm)24.30B
Shares Out17.77M
EPS (ttm)2,243.00
PE Ratio5.25
Forward PEn/a
Dividend510.00 (4.33%)
Ex-Dividend DateDec 27, 2024
Volume13,478
Average Volume16,612
Open11,850
Previous Close11,790
Day's Range11,750 - 11,880
52-Week Range10,050 - 12,500
Beta0.42
RSI47.16
Earnings DateAug 20, 2025

About Hana Pharm

Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1996 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1996
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 293480
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.